Anne Daub, Biotechnology Analyst
Anne Daub is an investment analyst in the U.S. Equity Division, covering biotechnology stocks. She is a vice president of T. Rowe Price Group, Inc., and a member of the Investment Advisory Committee of the Diversified Mid-Cap Growth and Health Sciences Funds.
Anne’s investment experience began in 1998, and she has been with T. Rowe Price since 2018. Prior to this, Anne was employed by Soros Fund Management in New York, with a primary focus on oncology, hematology, endocrinology, metabolic disorder, and orphan disease companies. Anne also was employed at Citadel LLC, covering biotechnology companies.
Anne earned an M.B.A. in finance from Hautes Etudes Commerciales Graduate School of Management in Paris, France.
- Years at T. Rowe Price5
- Years investment experience0